Emmet Mc Cormack

Emmet Mc Cormack is a Professor in the Department of Clinical Science at the University of Bergen, specializing in Translational Molecular Imaging in Cancer. His research focuses on preclinical model development, multimodal imaging, and pharmaceutical drug development for cancers including leukemia, ovarian cancer, and pancreatic adenocarcinoma.

Research interests span cancer biology, molecular imaging, and targeted drug delivery systems. Key areas include developing bioluminescent orthotopic models, ultrasound-enhanced chemotherapy, nanoparticle-based therapies, and leukemia stem cell mechanisms.

Publications demonstrate strong focus on oncology therapeutics, with recent work emphasizing imaging-guided treatments, xenograft models, and molecular mechanisms of drug resistance. Research consistently integrates multimodal imaging techniques with pharmacological interventions.

Key projects include SonoCURE (sonoporation-enhanced therapy for pancreatic cancer) and AML-VACCiN (dendritic-cell vaccine therapy for acute myeloid leukemia), funded by Research Council of Norway and EU H2020 programs. Leads the Translational Molecular Imaging in Cancer research group developing advanced preclinical models.